United States · Platforms & data · The Motley Fool

Cerus (CERS) Q3 2026 Earnings Call Transcript

Published by The Motley Fool · United States 2 h ago

REDeS trial met efficacy endpoints; ISC revenue surged 44% year over year.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Fortis Non-GAAP EPS of C$0.92 beats by C$0.04

10,328 Shares in Honeywell Aerospace $HONA Bought by Providence Wealth Advisors LLC

Oil has had a massive run, but a prominent bull sees a turning point on midterm eve

Blackstone president calls for more equity to fund AI buildout as debt risks mount

‘The Debt Is Not the Problem’: Ramsey Host to Stay-at-Home Mom of 7 Who Borrowed Student Loans for Groceries

Palantir Earnings: We Raise Fair Value Estimate as AI Growth Accelerates